Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.54 |
| ▸ | POLB | P06746 | 2/20 | 0.54 |
| ▸ | MAPT | P10636 | 2/20 | 0.54 |
| ▸ | APEX1 | P27695 | 2/20 | 0.54 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.54 |
| ▸ | ELANE | P08246 | 2/20 | 0.54 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.54 |
| ▸ | ESR1 | P03372 | 2/20 | 0.54 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.54 |
| ▸ | NPC1 | O15118 | 1/20 | 0.54 |
| ▸ | PTP4A3 | O75365 | 1/20 | 0.54 |
| ▸ | GMNN | O75496 | 1/20 | 0.54 |
| ▸ | LMNA | P02545 | 1/20 | 0.54 |
| ▸ | TP53 | P04637 | 1/20 | 0.54 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23522434 | 0.84 | MEN1 (0.54) | MEN1CYP3A4KMT2AALDH1A1POLB | |
| SCHEMBL16225752 | 0.83 | EGFR (0.58) | MEN1CYP3A4KMT2AALDH1A1POLB | |
| SCHEMBL2771631 | 0.78 | BCL2 (0.76) | MEN1CYP3A4KMT2AALDH1A1POLB | |
| SCHEMBL16226740 | 0.77 | ELANE (0.62) | MEN1CYP3A4KMT2AALDH1A1POLB | |
| SCHEMBL9175356 | 0.77 | BCL2 (0.69) | MEN1CYP3A4KMT2AALDH1A1POLB | |
| SCHEMBL23486220 | 0.77 | ALDH1A1 (0.73) | MEN1CYP3A4KMT2AALDH1A1POLB | |
| SCHEMBL29390162 | 0.76 | ESR1 (0.77) | MEN1CYP3A4KMT2AALDH1A1POLB | |
| SCHEMBL5968219 | 0.76 | ESR1 (0.77) | MEN1CYP3A4KMT2AALDH1A1POLB | |
| SCHEMBL29711665 | 0.76 | ELANE (0.50) | MEN1CYP3A4KMT2AALDH1A1POLB | |
| SCHEMBL28188374 | 0.74 | LCK (0.56) | MEN1CYP3A4KMT2AALDH1A1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180146683-A1 | NEW PRODUCT | ALPHA BIOPESTICIDES LIMITED (GB) | 2018-05-31 | — | — | US | claimed |
| EP-3302066-A1 | NEW PRODUCT | Alpha Biopesticides Limited (GB) | 2018-04-11 | — | — | EP | claimed |
| WO-2016189329-A1 | NEW PRODUCT | ALPHA BIOPESTICIDES LIMITED (GB) | 2016-12-01 | — | — | WO | claimed |
| CN-107846904-B | New product | 阿尔法生物农药有限公司 | 2022-02-08 | — | — | CN | disclosed |
| US-11019825-B2 | Product | ALPHA BIOPESTICIDES LIMITED (GB) | 2021-06-01 | — | — | US | disclosed |
| US-20180146683-A1 | NEW PRODUCT | ALPHA BIOPESTICIDES LIMITED (GB) | 2018-05-31 | — | — | US | disclosed |
| EP-3302066-A1 | NEW PRODUCT | Alpha Biopesticides Limited (GB) | 2018-04-11 | — | — | EP | disclosed |
| WO-2016189329-A1 | NEW PRODUCT | ALPHA BIOPESTICIDES LIMITED (GB) | 2016-12-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180146683-A1 | NEW PRODUCT | CYP51A1, ERG28, FASN | MEN1 3789/4885CYP3A4 882/4885KMT2A 2122/4885 |
| US-11019825-B2 | Product | ERG28, FASN, CYP51A1 | MEN1 2855/4885CYP3A4 902/4885KMT2A 1852/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.